(2024)
Mod5 mediates a molecular trade-off between optimal gene expression and antifungal resistance.
bioRxiv
[Preprint]
Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Leitung +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Forschungsschwerpunkte
- Medizinische & Umweltmetagenomik: Mensch, Maus, Pflanzen, marine Lebewesen
- Systembiologie: Integration von –omics-Daten; Molekül/ Protein & Protein/ Protein Netzwerke
- Synthetische Biologie: Metabolische Modellierung auf Genomausmaß, Design von Probiotika, Entdeckung von Postbiotika
Publikationen
(2024)
Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in obese Chinese.
Comput Struct Biotechnol J 23(2024),
791-800.
(2024)
In-vitro influence of specific Bacteroidales strains on gut and liver health related to Metabolic dysfunction-associated fatty liver disease.
Probiotics Antimicrob Proteins
[Epub ahead of print]
(2024)
Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota.
Nat Metab 6(3),
578-597.
(2024)
A global survey of host, aquatic, and soil microbiomes reveals shared abundance and genomic features between bacterial and fungal generalists.
Cell Rep 43(4),
114046.
(2024)
Life goes on: Spatial heterogeneity promotes biodiversity in an urbanized coastal marine ecosystem.
Glob Chang Biol 30(4),
e17248.
(2024)
Controlling substrate- and stereospecificity of condensation domains in nonribosomal peptide synthetases.
ACS Chem Bio 19(3),
599-606.
(2024)
Candida albicans translocation through the intestinal epithelial barrier is promoted by fungal zinc acquisition and limited by NFκBmediated barrier protection.
Plos Pathogens 20(3),
e1012031.
(2023)
High-throughput profiling of Candida auris isolates reveals clade-specific metabolic differences.
Microbiol Spectr 11(3),
e0049823.
(2023)
Human TH17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activation.
Nat Immunol 24(2),
295-308.